Aramark (ARMK) has just reported fresh numbers for Q2 2026, with Q1 2026 revenue of US$4.8b and basic EPS of US$0.37 setting the tone as investors weigh the latest run of results against the stock’s recent share price around US$48.41. Over the past year, revenue has moved from US$4.3b in Q2 2025 to US$4.8b in Q1 2026, while basic EPS has shifted from US$0.23 in Q2 2025 to US$0.37 in Q1 2026. This gives a clear view of how the top line and per share profitability have tracked into this print. With trailing net profit margins sitting in the low single digits and forecasts pointing to earnings growth, this set of results invites a closer look at how durable those margins might be.

See our full analysis for Aramark.

With the headline numbers in place, the next step is to see how they line up with the prevailing stories around Aramark, highlighting where the data backs those narratives and where it starts to push back.

1.7% net margin keeps profits thin

• Over the last 12 months, Aramark generated US$18.8b of revenue and US$316.9m of net income, which works out to a 1.7% net margin compared with 1.9% a year earlier.
• Analysts' consensus view is that high-quality past earnings and contract wins can support higher profitability over time. However, the slim 1.7% margin and exposure to rising labor and medical costs mean any cost pressure or contract loss can quickly show up in earnings.
• Consensus points to technology and AI investments and health focused offerings as margin helpers, but the data still shows margins under 2% on US$18.8b of sales.
• Concerns around labor costs and unionized workforces sit squarely against this, because even small cost increases are material when starting from a 1.7% margin base.

Earnings growth vs 40.1x P/E valuation

• Trailing earnings are forecast to grow about 12.4% per year while the stock trades on a 40.1x P/E, above both peers at 37.5x and the US Hospitality industry at 20.2x, and above a DCF fair value of US$32.88 compared with a current share price around US$48.41.
• Bears argue that paying a premium P/E on top of a share price that sits above DCF fair value leaves little room for disappointment, and the data here leans toward that concern.
• The gap between US$48.41 and the DCF fair value of US$32.88 points to a sizeable valuation cushion already priced in before any execution risk on contracts, margins or interest costs is considered.
• With revenue growth forecasts around 5.6% per year and earnings growth forecasts below the broader US market at 16.7%, the premium 40.1x multiple and thin 1.7% margin give bears specific numbers to focus on rather than just general caution.

On these numbers, skeptics see more pressure on the current share price than support for a re rating, especially with margins and interest coverage both under scrutiny. 🐻 Aramark Bear Case

US$18.8b sales but interest still a key risk

• Across the trailing 12 months Aramark generated US$18.8b of revenue and US$316.9m of net income, yet interest payments are flagged as not well covered by earnings, highlighting balance sheet pressure alongside the income statement.
• Consensus narrative highlights long dated contracts, strong retention in education and growth in international markets as supports for revenue stability, but the interest coverage warning shows that even with US$316.9m of annual earnings, financing costs remain a meaningful constraint.
• Winning and renewing major multi year contracts in sectors like sports and education helps underpin that US$18.8b revenue base, which lines up with the story of diversification and stability.
• At the same time, the need to service interest from a relatively small profit pool of US$316.9m means leverage is a central factor investors have to track, right alongside growth in contracts and international expansion.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Aramark on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

If the mix of thin margins, richer valuation and balance sheet questions feels finely balanced, move quickly to check the underlying data and form your own view. Then weigh both sides of the story with the 1 key reward and 1 important warning sign

See What Else Is Out There

Aramark’s thin 1.7% net margin, premium 40.1x P/E and interest coverage concerns together leave limited room for error if earnings or contracts soften.

If you want ideas where pricing and balance sheets look more comfortable, compare these results against the 69 resilient stocks with low risk scores today and see how the trade off feels.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.